Component
Progression to central geographic atrophy
Progression to central geographic atrophy. Species, exposure and limitations are retained in each linked claim.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
Central geographic atrophy HR was 0.94 (95% CI 0.70–1.26), without a significant difference.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lutein-research/24310343.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "617cbda47a00c8fc552395a255003b013afa72aca6640c5c2e49d2b4caf09a72", "start_char": 0, "end_char": 2419, "text_sha256": "617cbda47a00c8fc552395a255003b013afa72aca6640c5c2e49d2b4caf09a72"}
- experimental_model
- Exploratory secondary analyses of AREDS2
- exposure
- L+Z 10/2 mg; direct comparison with beta-carotene on AREDS background
- limitations
- Exploratory contrasts and different confidence thresholds do not contradict the prespecified primary analysis.
- nutrient_topic
- Lutein research collection; topical membership is not evidence of a direct dietary effect. · Lutein
- organism
- Same AREDS2 cohort, not an independent replication
- plain_language
- The same comparison did not show benefit for every subtype.
- primary_references
- [lutein-p24310343] Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3. (2014). https://pubmed.ncbi.nlm.nih.gov/24310343/ DOI: 10.1001/jamaophthalmol.2013.7376
- tissue_or_cell_type
- Late AMD subtypes
Lutein: metabolism, signaling and nutrient connections (2026-09-17) · lines 775–786
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Exploratory secondary analyses of AREDS2 · source_derived_draft · unverified_draft
### lutein-areds-replacement-atrophy-null Central geographic atrophy HR was 0.94 (95% CI 0.70–1.26), without a significant difference. Condition category: normal nutrient_topic: Lutein research collection; topical membership is not evidence of a direct dietary effect. plain_language: The same comparison did not show benefit for every subtype. organism: Same AREDS2 cohort, not an independent replication tissue_or_cell_type: Late AMD subtypes experimental_model: Exploratory secondary analyses of AREDS2 limitations: Exploratory contrasts and different confidence thresholds do not contradict the prespecified primary analysis. exposure: L+Z 10/2 mg; direct comparison with beta-carotene on AREDS background evidence_span: {"source_cache": "artifacts/lutein-research/24310343.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "617cbda47a00c8fc552395a255003b013afa72aca6640c5c2e49d2b4caf09a72", "start_char": 0, "end_char": 2419, "text_sha256": "617cbda47a00c8fc552395a255003b013afa72aca6640c5c2e49d2b4caf09a72"} [lutein-p24310343] Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3. (2014). https://pubmed.ncbi.nlm.nih.gov/24310343/ DOI: 10.1001/jamaophthalmol.2013.7376
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.